A detailed history of Woodline Partners LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Woodline Partners LP holds 750,322 shares of ABBV stock, worth $144 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares
750,322
Previous 638,393 17.53%
Holding current value
$144 Million
Previous $116 Million 10.7%
% of portfolio
1.29%
Previous 1.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $17.3 Million - $20.2 Million
111,929 Added 17.53%
750,322 $129 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $102 Million - $116 Million
-636,304 Reduced 49.92%
638,393 $116 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $4.31 Million - $4.86 Million
31,351 Added 2.52%
1,274,697 $198 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $110 Million - $127 Million
822,491 Added 195.43%
1,243,346 $185 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $7.84 Million - $9.75 Million
-59,150 Reduced 12.32%
420,855 $56.7 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $4.4 Million - $5.07 Million
30,431 Added 6.77%
480,005 $76.5 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $36.3 Million - $43.5 Million
262,486 Added 140.3%
449,574 $72.7 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $25.1 Million - $28.8 Million
187,088 New
187,088 $25.1 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $141 Million - $175 Million
-1,070,201 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $31.1 Million - $39.4 Million
289,792 Added 37.13%
1,070,201 $145 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $18.1 Million - $20.5 Million
169,879 Added 27.82%
780,409 $84.2 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $49.4 Million - $55 Million
469,295 Added 332.28%
610,530 $68.8 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $14.4 Million - $15.9 Million
141,235 New
141,235 $15.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $339B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.